A mathematical crystal ball gazes into future of prostate cancer treatment
The chemotherapy docetaxel is widely accepted as a standard therapy for metastatic castration-resistant prostate cancer. But 10-20 percent of patients will have adverse side effects that force discontinuation of treatment. ...
Aug 5, 2017
0
41